SARAH CHERRY: Open Payments
NPI 1750844890 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$82 in 4 payments from 3 companies in 2025. Trend: 2023 $197 · 2024 $32 · 2025 $82
Food & beverage: $82
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 2 | $44 |
| ACADIA Pharmaceuticals Inc | 1 | $23 |
| Otsuka America Pharmaceutical, Inc. | 1 | $15 |
Products named: INGREZZA, NUPLAZID, REXULTI.
Industry payments across IN — which companies pay providers there.
